Site updated at Wednesday, 22 June 2016

Living with Dementia

Early signs of Parkinson’s might be seen in colon

  • - Dementia News
  • May 16, 2012
  • Comments
  • Viewed: 1432
Tags: | alpha-synuclein | diagnose parkinson's | parkinson's disease | signs of parkinson's |

A colonoscopy or similar test could one day diagnose Parkinson’s disease years before symptoms occur. That’s because signs of Parkinson’s that appear in the brain also show up in the colon, a new study says.

Researchers examined tissue samples obtained during colon exams of people who later developed Parkinson’s disease. The samples were taken several years before the patients showed symptoms of the neurological disorder.

The cells in the patients’ intestinal walls were found to contain clumps of alpha-synuclein - a hallmark protein of Parkinson’s.

In a previous study, these researchers found these aggregates were apparently unique to the gut of Parkinson’s disease patients- they were not seen in people with certain gut disorders or in healthy people.

The findings suggest that tissue obtained during a colonoscopy or other colon cancer screening test could one day be used to predict who will develop Parkinson’s, said study researcher Dr. Kathleen Shannon, a neurologist at Rush University Medical Center in Chicago.

However, first the findings will need to be replicated in studies that include more people, including people with other types of brain diseases, the researchers said.

Currently doctors cannot diagnose Parkinson’s until patients show symptoms, such as shaking, slowed movements and stiff muscles. By then, however, the patients’ brains have deteriorated significantly. Finding early markers of the disease could lead to a way to slow or stop the progression, the researchers said.

Predicting Parkinson’s
Parkinson’s disease is caused by loss of brain cells that produce dopamine, a brain chemical needed to control muscle movement. One change that occurs in the brains of Parkinson’s patients is the formation of clumps called Lewy bodies. The protein alpha-synuclein is found in all Lewy bodies, according to the Mayo Clinic.

Recent research suggests the Parkinson’s disease process begins in nerve cells in the gut and spreads to nerves in the brain, Shannon said.

In a 2011 study, Shannon and colleagues examined intestinal tissue samples taken from nine Parkinson’s patients, 23 healthy people and 23 people with Crohn’s disease or ulcerative colitis (both types of inflammatory bowel disease). The people in the study ranged in age from early 20s to late 70s.

All nine Parkinson’s disease patients had clumps of alpha-synuclein in the nerves of their gut tissue, while none of the healthy people or people with gut disorders did. Two healthy people and three colitis patients had a small amount of alpha-synuclein in their cells, but it was distinct from the amount seen in the Parkinson’s patients.

In a study published today (May 15) in the journal Movement Disorders, the researchers reported they examined tissue samples from three patients taken during colonoscopies two to five years before the patients developed Parkinson’s disease symptoms. All the patients had the characteristic aggregates of alpha-synuclein in their gut.

Provoactive study
“It’s really interesting and provocative,” Dr. William Weiner, a neurologist at the University of Maryland School of Medicine and member of the American Academy of Neurology, said of the study findings. The hypothesis that Parkinson’s disease starts in the gut has not had much tangible evidence until now, Weiner said.

Page 1

1 2 Next »

Post a comment [ + Comment here + ]

There are no comments for this entry yet. [ + Comment here + ]

Your details

* Required field

Please enter the word you see in the image below:

Comments are moderated by our editors, so there may be a delay between submission and publication of your comment. Offensive or abusive comments will not be published.

Out of the shadows - Living with dementia

mental confusion4 - methamphetamine1 - prevent alzheimer's1 - dementia care4 - mood changes1 - imbecility1 - mild cognitive impairment22 - cholesterol1 - cognitive deficits1 - risk of developing parkinson's1 - frontotemporal degeneration1 - glucose hypometabolism1 - agitation2 - neurofilaments1 - rheumatoid arthritis1 - advanced dementia1 - impaired balance and coordination1 - mild traumatic brain injury1 - dementia with lewy bodies3 - rigidity1 - congestive heart failure1 - delay dementia1 - aphasia4 - progression of pd1 - risk for cognitive decline1 - brain amyloid imaging1 - protective effect1 - startle myoclonus1 - degree of dementia1 - prichard1 -